Your browser doesn't support javascript.
loading
Population Pharmacokinetics and Exposure-Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular Carcinoma.
Lim, KyoungSoo; Abegesah, Aburough; Fan, Chunling; He, Jimmy Zhijian; Song, Xuyang; Chen, Cecil; Negro, Alejandra; Makowsky, Mallory; Gupta, Charu; Ren, Song; Phipps, Alex; Gibbs, Megan; Zhou, Diansong.
Afiliação
  • Lim K; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Abegesah A; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Fan C; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • He JZ; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Song X; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Chen C; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA.
  • Negro A; Clinical Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Makowsky M; Clinical Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Gupta C; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Ren S; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Phipps A; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Gibbs M; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
  • Zhou D; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
J Clin Pharmacol ; 63(11): 1221-1231, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37300457

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos